CAM
NUVB.WS

Cormorant Asset Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Cormorant Asset Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-83,332
Closed -$217K – 96
2021
Q2 		$217K Hold
83,332
– – 0.01% 103
2021
Q1 		$222K Buy
+83,332
New +$241K ﹤0.01% 120

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Cormorant Asset Management's NUVB.WS Position: Q3 2021 in Review

Cormorant Asset Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q3 2021, closing a stake of 83,332 shares — an estimated $217K sold.

Cormorant Asset Management first reported a position in NUVB.WS in Q1 2021 and held it in 2 quarters. The position peaked at $222K in Q1 2021. 22 funds tracked by Wall St. Rank hold NUVB.WS as of Q3 2021.

  • Cormorant Asset Management reported no remaining Nuvation Bio Inc Warrants position as of Q3 2021 after selling out during the quarter.
  • Cormorant Asset Management sold 83,332 Nuvation Bio Inc Warrants shares in Q3 2021, an estimated $217K.
  • Cormorant Asset Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 2 quarters.
  • Cormorant Asset Management's Nuvation Bio Inc Warrants position peaked at $222K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q3 2021.

Based on Cormorant Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.